metformin and tofacitinib

metformin has been researched along with tofacitinib in 4 studies

Research

Studies (4)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's3 (75.00)24.3611
2020's1 (25.00)2.80

Authors

AuthorsStudies
Davis, MI; Khan, J; Li, SQ; Patel, PR; Shen, M; Sun, H; Thomas, CJ1
Afshari, CA; Chen, Y; Dunn, RT; Hamadeh, HK; Kalanzi, J; Kalyanaraman, N; Morgan, RE; van Staden, CJ1
Alvey, C; Dowty, ME; Feng, B; Kaplan, I; Klamerus, KJ; Krishnaswami, S; Li, L; Shi, H; Wang, R1
Akar, ZA; Akkoc, RF; Celik, C; Dagli, AF; Etem, EO; Karatas, A; Koca, SS; Oz, B1

Trials

1 trial(s) available for metformin and tofacitinib

ArticleYear
Evaluation of the potential interaction between tofacitinib and drugs that undergo renal tubular secretion using metformin, an in vivo marker of renal organic cation transporter 2.
    Clinical pharmacology in drug development, 2014, Volume: 3, Issue:6

    Topics: Administration, Oral; Adult; Area Under Curve; Belgium; Drug Interactions; Female; Healthy Volunteers; HEK293 Cells; Humans; Janus Kinase Inhibitors; Kidney Tubules; Male; Metformin; Middle Aged; Organic Cation Transporter 2; Piperidines; Pyrimidines; Pyrroles; Renal Elimination; Transfection; Young Adult

2014

Other Studies

3 other study(ies) available for metformin and tofacitinib

ArticleYear
Identification of potent Yes1 kinase inhibitors using a library screening approach.
    Bioorganic & medicinal chemistry letters, 2013, Aug-01, Volume: 23, Issue:15

    Topics: Binding Sites; Cell Line; Cell Survival; Drug Design; Humans; Hydrogen Bonding; Molecular Docking Simulation; Protein Kinase Inhibitors; Protein Structure, Tertiary; Proto-Oncogene Proteins c-yes; Small Molecule Libraries; Structure-Activity Relationship

2013
A multifactorial approach to hepatobiliary transporter assessment enables improved therapeutic compound development.
    Toxicological sciences : an official journal of the Society of Toxicology, 2013, Volume: 136, Issue:1

    Topics: Animals; ATP Binding Cassette Transporter, Subfamily B; ATP Binding Cassette Transporter, Subfamily B, Member 11; ATP-Binding Cassette Transporters; Biological Transport; Chemical and Drug Induced Liver Injury; Cluster Analysis; Drug-Related Side Effects and Adverse Reactions; Humans; Liver; Male; Multidrug Resistance-Associated Proteins; Pharmacokinetics; Rats; Rats, Sprague-Dawley; Recombinant Proteins; Risk Assessment; Risk Factors; Toxicity Tests

2013
Tofacitinib and metformin reduce the dermal thickness and fibrosis in mouse model of systemic sclerosis.
    Scientific reports, 2022, 02-15, Volume: 12, Issue:1

    Topics: Animals; Drug Therapy, Combination; Female; Fibrosis; Metformin; Mice; Mice, Inbred BALB C; Piperidines; Pyrimidines; Scleroderma, Systemic; Skin

2022